生物技术公司Absci Corporation（股票代码：ABSI）今日盘中股价大幅下跌14.85%，引发市场关注。这一显著跌幅可能与投资银行Needham最新的研究报告有关。
据悉，Needham分析师将Absci的目标股价从8美元下调至7美元。这一目标价的下调可能反映了分析师对公司未来增长前景的担忧，或是对公司当前估值的重新评估。目标价的下调通常会对投资者信心产生负面影响，从而导致股价下跌。
Absci Corporation是一家专注于蛋白质设计和生物制药的公司。目前尚不清楚Needham下调目标价的具体原因，投资者可能需要关注公司近期的财务表现、行业竞争态势以及未来发展战略等因素，以更全面地评估这次股价调整的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.